Also trades as: HEAL.CN (CNQ) · $vol 0M
NMLSF OTC
Restart Life Sciences Corp.
1W: +32.8%
1M: +11.8%
3M: +1.0%
YTD: -19.6%
1Y: +83.8%
3Y: -89.5%
5Y: -96.8%
$0.07
+0.00 (+7.03%)
Weekly Expected Move ±34.7%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
-100.0% ▼
Operating Income
-$624K
+48.1% ▲
Net Income
$225K
+118.4% ▲
EPS (Diluted)
$0.01
+117.3% ▲
EBITDA
-$656K
+45.4% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $11K | $0 | $0 | $0 | $0 |
| YoY Growth | +59.5% | -100.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $10K | $5K | $4K | $0 | $0 |
| Gross Profit | $2K | -$5K | -$4K | $25K | $0 |
| Gross Margin | 15.1% | — | — | — | — |
| R&D Expenses | $48K | $860K | $115K | $71K | $500 |
| SG&A Expenses | $2M | $2M | $2M | $1M | $402K |
| Operating Expenses | $2M | $3M | $2M | $1M | $624K |
| Operating Income | -$2M | -$3M | -$2M | -$1M | -$624K |
| Operating Margin | -13723.1% | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$25M | -$3M | -$2M | -$1M | $225K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$25M | -$3M | -$2M | -$1M | $225K |
| Net Margin | -219950.2% | — | — | — | — |
| EPS (Diluted) | $-4.93 | $-0.24 | $-0.18 | $-0.08 | $0.01 |
| EBITDA | -$2M | -$3M | -$2M | -$1M | -$656K |
| Shares Outstanding | 5M | 11M | 14M | 15M | 16M |